REVERSIBLE AIRWAYS OBSTRUCTION

This adverse event was reported 508 times

These drugs are most commonly taken by patients reporting REVERSIBLE AIRWAYS OBSTRUCTION:

# Drug Count
0 ALBUTEROL SULFATE 292
1 PREDNISONE 228
2 MEPOLIZUMAB 226
3 MONTELUKAST SODIUM 219
4 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 200
5 TIOTROPIUM BROMIDE 184
6 ALBUTEROL 172
7 OMALIZUMAB 141
8 ROSUVASTATIN CALCIUM 141
9 LEVOTHYROXINE SODIUM 132
See all common drugs associated with REVERSIBLE AIRWAYS OBSTRUCTION

REVERSIBLE AIRWAYS OBSTRUCTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CICLESONIDE 88 0.0064
1 GABAPENTIN ENACARBIL 18 0.0063
2 ROSUVASTATIN CALCIUM 141 0.0048
3 MEPOLIZUMAB 226 0.0045
4 NORTRIPTYLINE HYDROCHLORIDE 24 0.0040
5 THEOPHYLLINE ANHYDROUS 41 0.0033
6 TERBUTALINE SULFATE 6 0.0033
7 RABEPRAZOLE SODIUM 72 0.0026
8 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 200 0.0020
9 IPRATROPIUM BROMIDE 73 0.0020
See all drugs enriched for association with REVERSIBLE AIRWAYS OBSTRUCTION

REVERSIBLE AIRWAYS OBSTRUCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 226 0.3285
1 Anti-IgE [EPC] 141 0.0016
2 Methylxanthine [EPC] 42 0.0007
3 Cholinergic Nicotinic Agonist [EPC] 43 0.0007
4 Leukotriene Receptor Antagonist [EPC] 19 0.0006
5 Nitrate Vasodilator [EPC] 52 0.0006
6 Nitroimidazole Antimicrobial [EPC] 38 0.0006
7 Aldosterone Antagonist [EPC] 89 0.0006
8 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
9 Serotonin Reuptake Inhibitor [EPC] 35 0.0004
See all drug classes enriched for association with REVERSIBLE AIRWAYS OBSTRUCTION